CSF Aβ1‐42 (P < .01) and p‐tau (P = .05) levels were lower in PD patients when compared with HCs, but t‐tau (P = .08) levels did not differ between PD and HCs (Table 2). The gene discussed is MAPT; the disease is Parkinson disease.